Cannabis Law Report
DECEMBER 3, 2021
.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-Clustering Epilepsy (the Violet Study). About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc.
MMJ Recs
NOVEMBER 17, 2023
The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
FEBRUARY 21, 2023
This suggests that not only may MMJ-restrictive states be failing their citizens by denying access to a proven therapy option, but they may also be unknowingly fostering habits that could increase the risks associated with the long-term use of potentially deadly pharmaceutical medications.
CannaTech
AUGUST 9, 2018
We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.
MMJ Recs
FEBRUARY 3, 2024
Common qualifying conditions include: Chronic pain Cancer Epilepsy Post-traumatic stress disorder (PTSD) Understanding the eligibility criteria is essential for patients seeking relief through medical marijuana. This can lead to a decreased reliance on pharmaceuticals that may adversely affect patients’ health and overall lifestyle.
Cannabis Law Report
JUNE 26, 2019
Fried also strongly delivered a message that could have been taken straight out of my own mouth: “This is a plant that not only improves people’s quality of life, it’s an alternative to sometimes-dangerous pharmaceuticals and addictive opioids.” Jacel Delgadillo. Eric Stevens. Antoinette Duncan. 15, Peter Barsoom.
Veriheal
AUGUST 31, 2020
Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Combining Social Sciences and Pharmacology to Make a Positive Social Impact in Cannabis” . School: University of Maryland.
Expert insights. Personalized for you.
52 
Let's personalize your content